12-57243885-G-A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145064.3(STAC3):c.1022C>T(p.Ala341Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000026 in 1,613,732 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. A341A) has been classified as Likely benign.
Frequency
Consequence
NM_145064.3 missense
Scores
Clinical Significance
Conservation
Publications
- Bailey-Bloch congenital myopathyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, ClinGen, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STAC3 | NM_145064.3 | c.1022C>T | p.Ala341Val | missense_variant | Exon 12 of 12 | ENST00000332782.7 | NP_659501.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152072Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000200 AC: 5AN: 250334 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000239 AC: 35AN: 1461660Hom.: 0 Cov.: 32 AF XY: 0.0000248 AC XY: 18AN XY: 727126 show subpopulations
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152072Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74294 show subpopulations
ClinVar
Submissions by phenotype
Bailey-Bloch congenital myopathy Uncertain:2
- -
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 341 of the STAC3 protein (p.Ala341Val). This variant is present in population databases (rs753014378, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with STAC3-related conditions. ClinVar contains an entry for this variant (Variation ID: 851418). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt STAC3 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.1022C>T (p.A341V) alteration is located in exon 12 (coding exon 11) of the STAC3 gene. This alteration results from a C to T substitution at nucleotide position 1022, causing the alanine (A) at amino acid position 341 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at